{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        732, 
        746
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1115, 
        1135
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        616, 
        643
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        496, 
        522
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        713, 
        721
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        748, 
        755
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        762, 
        763
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        722, 
        731
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        645, 
        647
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        647, 
        649
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 8^9999^MOH|PIMS|CCO|201605061822|76952CCF1B18CE806172EBBAE995DF34B0E45073|ORU^R01|PIMS-OUT.1.184032|P|2.5|\nPID|1||9999999999^^^^CMR^HOSPITAL 8&9999&MOH~9999999999^^^^MRN^HOSPITAL 8&9999&MOH~999999999&&NB^^^^JHN||XXXXXX^XXXXXXX^^^^||99999999|M|||9 XXX XXXXXXXXX^^XXXXX XXXXXXX^XX^X9X 9X9^999|||||||||||||||||||N|\nOBR|1||16:CR219|11529-5^Surgical Pathology Study Report^LN^P^Pathology^L|||20160315|||^^^^^^||||||||||||20160506|||F|||||||99999^XXXXXXX^XXXX^^^^|\n\n\n\n\n\n\n\nPath report.site of origin\n\nA: Pathology Case Review, 62 S/S  1 BLOCK#5 (ES-16-671 (PART A); VITALITE HEALTH NETWORK)\n\n\nPath report.final diagnosis\n\nA.B. PROSTATECTOMY (PARTIAL) AND EXCISION OF PROSTATIC CAPSULE:\n \n- INVASIVE PROSTATIC ADENOCARCINOMA, GLEASON SCORE 9(5,4) WITH FOCAL\n NEUROENDOCRINE DIFFERENTIATION:\n \n  I) PROGNOSTIC GRADE GROUP (ISUP GRADE) 5/5.\n   \n  II) EXTENSIVE INTRADUCTAL CARCINOMA (IDC).\n   \n III) ABOUT 50-60% OVERALL TISSUE INVOLVEMENT.\n   \n  IV) FOCAL EXTRAPROSTATIC EXTENSION.\n  \n  V) FOCAL INVOLVEMENT OF SEMINAL VESICLE-TYPE TISSUE (SEE COMMENT).\n \n  VI) MULTIFOCAL MARGIN POSITIVITY.\n\n\nPath report.comments\n\nThis prostatectomy specimen is received in 2 parts and the orientation is\nunclear. There is an extensive high grade invasive adenocarcinoma with focal\nneuroendocrine differentiation. Extensive intraductal carcinoma (IDC) is also\nseen. The tumour shows focal extraprostatic spread and involves seminal\nvesicle-type tissue, however, it is unclear whether this seminal vesicle tissue\nis intraprostatic or extraprostatic. Only the latter would indicate pT3b\ndisease. This tumour is at least pT3a and shows multifocal margin positivity.\n\n\n"
}